We hope that our move will contribute to the growing success of Cambridge. Today’s announcement also confirms AstraZeneca’s long-standing commitment to the UK and increases the chances that ...

Albireo Limited, a privately held spinout from AstraZeneca (NYSE ... why he moved the Sweden-based business to a small office at the Cambridge Innovation Center. His answer: for the “buzzy ...

AstraZeneca succeeded in thwarting Pfizer's takeover plans – but was forced to promise investors that it could deliver very rapid growth – forecasting revenues of $45 billion by 2023, compared ...

AstraZeneca has an office on Hills Road ... Chesterford Research Park, Cambridge Science Park, and the Cambridge Biomedical Campus. You can also enter your address at the top of this page in ...

AstraZeneca announced a strategic research collaboration with CSPC Pharmaceuticals to advance AI-enabled drug discovery. This partnership aims to develop novel o ...

The new Global R&D Centre will become the focal point for oncology research within AstraZeneca worldwide. Your forte could be the lab or Biometrics, Projects or Regulatory. Join us in Cambridge or ...

AstraZeneca AZN0.60%increase; green up pointing triangle plans to spend GBP650 million ($828.8 million) on vaccine programs and various other initiatives in the U.K. The pharmaceutical company ...

calling the Cambridge-headquartered pharma firm’s vaccine “a defective product,” according to the Daily Mail. AstraZeneca, which is contesting the claims, acknowledged in a February legal ...

[CAMBRIDGE, UK] Drugmaker AstraZeneca said on Monday (Mar 17) it will buy biotechnology firm EsoBiotec for up to US$1 billion. EsoBiotec’s Engineered NanoBody Lentiviral (ENaBL) platform can ...

CAMBRIDGE, Britain (AP) — CAMBRIDGE, Britain (AP) — Astrazeneca PLC (AZN) on Tuesday reported first-quarter profit of $2.92 billion. On a per-share basis, the Cambridge, Britain-based company ...